February is National Heart Health Month, which aims to raise awareness and encourage conversation about heart issues, ...

Subcutaneous injection of abelacimab results in lower levels of free factor XI and significantly fewer bleeding events than rivaroxaban in patients with atrial fibrillation at moderate-to-high risk ...

During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed the data supporting the 2 newer BTK ...

AFib causes an irregular heart rate that can make your heart feel as if it is fluttering or skipping beats. Panic attacks, on ...

Background Studies have shown an increased risk of cardiac disease following COVID-19, but how it compares to pneumonia of ...

Flossing your teeth at least once a week may be linked to a lower risk of stroke caused by a blood clot blocking brain blood ...

HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

Doylestown Health is broadening its treatment options for atrial fibrillation patients with a revolutionary system that ...

Poor oral health could be a potential risk factor for cardiovascular disease. New research shows that good oral health habits ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

Brukinsa had a lower risk of disease progression or death versus Imbruvica, as well as a more favorable safety profile, in R/R CLL and SLL.